Human growth hormone peaks in your mid-20s and declines by roughly 14% per decade after that. By 60, most adults are operating with a fraction of the growth hormone output that drove their cellular repair in younger years. Peptide therapy targets this decline directly. Rather than replacing growth hormone synthetically, therapeutic peptides stimulate the pituitary gland to produce more of it naturally. The result is improved cellular repair, better body composition, deeper sleep, and a measurable reduction in the physiological markers of aging.
Topics
